IEX

IDEX Corporation 10-Q Summary: Period Ended June 30, 2007

Business Context and Reporting Period

This is a Quarterly Report (Form 10-Q) for IDEX Corporation, a Delaware corporation specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire/safety products. The report covers the three and six-month periods ended June 30, 2007. The company operates as a large accelerated filer with 81,387,088 shares of common stock outstanding as of July 31, 2007.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 16% in Q2 and 20% for the six-month period compared to the prior year. Growth was driven by 7% organic base business growth, 11% from acquisitions, and 2% from favorable foreign currency translation.
• Margin Expansion: Gross margins improved to 42.8% in Q2 (from 41.5%) and 42.4% for the six months (from 41.4%). Operating margins expanded by 110 basis points in Q2 and 80 basis points for the six months, attributed to volume leverage and operational excellence.
• Acquisitions: The company acquired Faure Herman SA (Feb 2007) and Quadro Engineering (June 2007), contributing significantly to the Fluid & Metering Technologies segment.
• Discontinued Operations: Results for the Halox and Lubriquip businesses are reported as discontinued operations. The company recorded a loss of $0.2M from discontinued operations in Q2 2007.
• Debt Structure: Short-term borrowings increased significantly to $158.2M (from $8.2M in Dec 2006) due to the reclassification of $150M Senior Notes due in Feb 2008 and new borrowings to fund acquisitions.

Guidance, Outlook, and Risks

Outlook: Management believes IDEX is well-positioned for earnings expansion due to a favorable cost structure, investment in new products, and strategic acquisitions. The company views itself as a short-cycle business reliant on current incoming orders with limited visibility on future conditions.

Liquidity: The company maintains a $600M revolving credit facility with $434.3M available. It is in compliance with financial covenants (minimum interest coverage 3.0:1, maximum leverage 3.25:1). Management expects sufficient cash flow to meet operating requirements, debt service, and dividends for the next 12 months.

Risks and Contingencies:

• Legal Proceedings: IDEX is a defendant in various asbestos-related lawsuits. While insurance has covered most costs to date, the company cannot predict future insurance availability. No material adverse effect is currently expected.
• Market Risks: Exposure to interest rate fluctuations (54% of debt is floating) and foreign currency exchange rates (primarily Euro and British Pound).
• Accounting Changes: The company adopted FIN 48 (Accounting for Uncertainty in Income Taxes) effective Jan 1, 2007, resulting in a $1.2M cumulative-effect adjustment reducing retained earnings.

Investor Verification Checklist

• Debt Maturity: Verify the refinancing strategy for the $150M Senior Notes due February 15, 2008, which are currently classified as short-term debt.
• Acquisition Integration: Monitor the integration and profitability contribution of Faure Herman and Quadro Engineering, which drove a significant portion of Q2 growth.
• Asbestos Litigation: Review updates on insurance coverage status for asbestos-related claims, as future coverage is uncertain.
• Organic Growth Sustainability: Assess whether the 7% organic growth rate is sustainable given the company's reliance on short-cycle order books.
• Capital Allocation: Track future capital expenditures and potential share repurchases against the $434.3M available credit facility.